U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
138931138931Lymphoma Follow-upCompletedNo Results AvailableLymphomahttps://ClinicalTrials.gov/show/NCT00744120
138932138932Cobra II Study: Use of the Cobraâ„¢ Cobalt Super Alloy Coronary Stent System in the Treatment of Coronary Artery DiseaseActive, not recruitingNo Results AvailableCoronary Artery DiseaseDevice: PCI with the Cobraâ„¢ Cobalt Super Alloy Coronary Stent Systemhttps://ClinicalTrials.gov/show/NCT00744107
138933138933Resistance Training in ElderlyCompletedNo Results AvailableSarcopenia|Atrophy|AgingDietary Supplement: protein drink|Behavioral: Resistance traininghttps://ClinicalTrials.gov/show/NCT00744094
138934138934Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)RecruitingNo Results AvailableAMLDrug: Glivec|Drug: Mitoxantrone|Drug: Topotecan|Drug: AraChttps://ClinicalTrials.gov/show/NCT00744081
138935138935Four Models of Telephone Support for Stimulant RecoveryCompletedNo Results AvailableDrug AddictionBehavioral: Continuing Care Telephone Supporthttps://ClinicalTrials.gov/show/NCT00744068
138936138936Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).CompletedNo Results AvailableAlcohol Dependence|Stress Disorders, Post-TraumaticDrug: Prazosin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00744055
138937138937Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)CompletedHas ResultsHypophosphatasia (HPP)Biological: asfotase alfahttps://ClinicalTrials.gov/show/NCT00744042
138938138938Reduction of Prehospital Delays in Stroke and Transient Ischaemic Attack (TIA)CompletedNo Results AvailableStrokeBehavioral: educational materialhttps://ClinicalTrials.gov/show/NCT00744029
138939138939Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative ColitisCompletedNo Results AvailableUlcerative ColitisDrug: Granulated mesalamine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00744016
138940138940An Observational Study of Early Coagulopathy, or Clotting Disorder, in Injured PatientsWithdrawnNo Results AvailableTrauma-induced Coagulopathyhttps://ClinicalTrials.gov/show/NCT00744003
138941138941Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal CoughCompletedNo Results AvailableRespiratory Tract DiseasesOther: Ointment containing camphor, eucalyptus oil, and menthol|Other: Petroleum jellyhttps://ClinicalTrials.gov/show/NCT00743990
138942138942Bioequivalence of Phenazopyridine HCl in Healthy VolunteersActive, not recruitingNo Results AvailableHuman VolunteersDrug: Phenazopyridine HClhttps://ClinicalTrials.gov/show/NCT00743977
138943138943Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)CompletedNo Results AvailableAdvanced Gastric CancerDrug: Epirubicin|Drug: Cisplatin, capecitabinehttps://ClinicalTrials.gov/show/NCT00743964
138944138944Feasibility Study: Effect of Patient Decision Aids for Total Joint Replacement on Surgical ReferralsCompletedNo Results AvailableOsteoarthritisBehavioral: 1 Patient decision aid|Behavioral: 2 Usual carehttps://ClinicalTrials.gov/show/NCT00743951
138945138945A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLCCompletedNo Results AvailableNon Small Cell Lung CancerDrug: BMS-690514|Drug: Erlotinibhttps://ClinicalTrials.gov/show/NCT00743938
138946138946FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary SyndromesCompletedNo Results AvailableAcute Coronary SyndromeDrug: Varespladib Methyl (A-002)https://ClinicalTrials.gov/show/NCT00743925
138947138947Open-Label Study to Evaluate the Effect of Rifaximin on Midazolam in Normal Healthy VolunteersCompletedNo Results AvailablePharmacokineticDrug: rifaximinhttps://ClinicalTrials.gov/show/NCT00743912
138948138948Conservative Versus Aggressive Revascularization in Patients With Intermediate Lesions Undergoing Percutaneous Coronary Intervention With Angiography Guidance AloneActive, not recruitingNo Results AvailableCoronary Artery DiseaseProcedure: The aggressive group|Procedure: The conservative grouphttps://ClinicalTrials.gov/show/NCT00743899
138949138949Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) TearWithdrawnNo Results AvailableMCL TearBiological: Plasma Rich in Growth Factors (PRGF)|Drug: salinehttps://ClinicalTrials.gov/show/NCT00743886
138950138950Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar DislocationCompletedNo Results AvailablePatella-DislocationBiological: Plasma Rich in Growth Factors (PRGF)|Drug: placebohttps://ClinicalTrials.gov/show/NCT00743873
138951138951A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848CompletedNo Results AvailableAtherosclerosisDrug: darapladibhttps://ClinicalTrials.gov/show/NCT00743860
138952138952A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With SchizophreniaWithdrawnNo Results AvailableSchizophreniaDrug: placebo|Drug: varenicline|Drug: vareniclinehttps://ClinicalTrials.gov/show/NCT00743847
138953138953Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD)Not yet recruitingNo Results AvailableObsessive Compulsive DisorderDrug: Luvox CR|Behavioral: Behavioral Therapyhttps://ClinicalTrials.gov/show/NCT00743834
138954138954Eye-Tracking Rapid Attention ComputationCompletedNo Results AvailablePost Concussive Syndrome, Chronichttps://ClinicalTrials.gov/show/NCT00743821
138955138955Hypertension and Diabetes Initiative - Improving Hypertension Control in Individuals With DiabetesCompletedNo Results AvailableHypertensionOther: quality improvementhttps://ClinicalTrials.gov/show/NCT00743808
138956138956Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV InfectionCompletedNo Results AvailableHCV InfectionDrug: placebo|Drug: GS-9190|Drug: Peginterferon Alfa 2a|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00743795
138957138957Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic HypoparathyroidismCompletedNo Results AvailableHypoparathyroidism|HypocalcemiaDrug: Synthetic Human Parathyroid Hormone 1-34https://ClinicalTrials.gov/show/NCT00743782
138958138958A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy VolunteersCompletedNo Results AvailableMyocardial Infarction|Myocardial IschemiaDrug: thymosin beta 4|Other: Placebohttps://ClinicalTrials.gov/show/NCT00743769
138959138959Study of a Home Delivered Meal Program on Obese Elderly African American Subjects With Type 2 Diabetes Mellitus (DM)TerminatedNo Results AvailableObesity|DiabetesDietary Supplement: home-delivered meals|Dietary Supplement: home-delivered meals|Behavioral: diabetes education for 12 monthshttps://ClinicalTrials.gov/show/NCT00743756
138960138960Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's DiseaseWithdrawnNo Results AvailableAlzheimer DiseaseDietary Supplement: Longevinex brand resveratrol supplement|Dietary Supplement: placebohttps://ClinicalTrials.gov/show/NCT00743743

* Görseller ve İçerik tekif hakkına sahip olabilir